MRI Interventions, Inc., a medical device company, develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging guidance primarily in the United States. The company offers ClearPoint system, a neuro intervention system that is used to perform minimally invasive surgical procedures in the brain. It is also developing ClearTrace system, a cardiac intervention system for performing minimally invasive surgical procedures in the heart.

Employee Rating

4.0More
TypePublic
HQIrvine, US
Founded1998
Size (employees)34 (est)+4%
Websitemriinterventions.com
MRI Interventions was founded in 1998 and is headquartered in Irvine, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at MRI Interventions

Joseph M. Burnett

Joseph M. Burnett

CEO
Peter G. Piferi

Peter G. Piferi

COO
Harold A. Hurwitz

Harold A. Hurwitz

CFO
Show more

MRI Interventions Office Locations

MRI Interventions has an office in Irvine
Irvine, (HQ)
5 Musick
Show all (1)
Report incorrect company information

MRI Interventions Financials and Metrics

MRI Interventions Revenue

MRI Interventions's revenue was reported to be $7.38 m in FY, 2017
USD

Revenue (Q3, 2018)

1.8m

Gross profit (Q3, 2018)

1.3m

Gross profit margin (Q3, 2018), %

69.4%

Net income (Q3, 2018)

(1.4m)

EBIT (Q3, 2018)

(1.2m)

Market capitalization (8-Oct-2018)

21.5m

Cash (30-Sep-2018)

3.7m
MRI Interventions's current market capitalization is $21.5 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

3.9m3.6m4.6m5.7m7.4m

Revenue growth, %

(8%)27%25%

Cost of goods sold

2.9m

Gross profit

4.5m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

927.5k822.5k1.2m633.2k1.0m825.7k1.2m1.4m1.1m1.6m2.0m2.0m1.7m1.6m1.6m1.8m

Cost of goods sold

589.0k602.2k553.2k

Gross profit

1.0m1.0m1.3m

Gross profit Margin, %

64%63%69%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

3.5m9.2m5.4m3.3m9.3m

Accounts Receivable

770.4k468.9k1.2m865.9k949.4k

Inventories

1.5mwdxefcqufszuzezftuxetqsqxt29.2k1.8m1.8m2.3m

Current Assets

5.9m11.7m8.5m6.1m12.7m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

5.0m5.8m4.1m1.9m6.4m3.5m1.9m3.6m2.0m4.4m2.0m12.7m11.0m7.5m6.7m3.7m

Accounts Receivable

787.7k452.7k599.1k548.8k605.7k487.1k837.4k1.5m769.7k803.5k1.0m750.8k910.1k770.8k1.1m

Inventories

1.2m1.7m1.9m2.3m2.1m2.1m1.8m1.6m1.6m1.8m1.8m1.9m2.2m2.5m2.7m2.5m

Current Assets

7.2m8.0m6.7m4.7m9.2m6.3m4.6m6.8m4.7m7.6m4.9m15.7m14.3m11.1m10.5m7.5m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(7.1m)(4.5m)(8.4m)(8.1m)(7.2m)

Depreciation and Amortization

211.9k155.7k116.5k

Inventories

(309.6k)145.7k68.6k72.3k(469.9k)

Accounts Payable

(695.3k)1.1m(436.4k)178.4k(512.4k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(5.4m)2.6m1.0m(2.6m)(3.9m)(7.0m)(7.3m)(2.0m)(3.8m)(6.4m)(1.7m)(3.7m)(5.1m)(1.6m)(3.5m)(4.9m)

Depreciation and Amortization

41.0k88.7k125.1k36.1k65.8k92.7k31.6k55.4k81.2k

Inventories

(355.7k)(147.9k)(299.6k)(657.9k)(188.1k)84.0k217.9k51.5k(34.0k)(62.0k)

Accounts Payable

(678.0k)(85.7k)677.0k1.2m1.1m(885.8k)(778.0k)52.8k(193.1k)(220.3k)5.1k(279.4k)(270.5k)(500.9k)(197.9k)(361.9k)
USDY, 2018

Financial Leverage

3.5 x
Show all financial metrics
Report incorrect company information

MRI Interventions Online and Social Media Presence

Embed Graph
Report incorrect company information

MRI Interventions News and Updates

MRI Interventions Reports Record ClearPoint® Cases and Disposable Functional Neurosurgery Revenue in Third Quarter

IRVINE, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC) (the “Company”) today announced financial results for its third fiscal quarter ended September 30, 2018.

MRI Interventions and Clinical Laserthermia Systems (CLS) Announce Collaboration to Develop Next-Generation Navigation and Laser Ablation Platforms for Neurosurgery -- UPDATE

Under the terms of the agreement, MRIC acquires worldwide exclusive rights to the platform for use in Neurosurgery and Spine with CLS as manufacturer

MRI Interventions and Monteris Medical Announce Collaboration to Develop Next-Generation Head Fixation Frames for Laser Ablation Neurosurgery

IRVINE, Calif., Oct. 12, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) and Monteris Medical, Inc. today announced a collaborative co-development agreement to provide a next-generation head fixation frame for use in laser ablation neurosurgery. Under terms of the agreement, Monteris…

MRI Interventions Retires Brainlab Debt, Extends 2019 Notes by 18 Months

IRVINE, Calif. , Sept. 25, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), announced today that the company has repaid in full and retired $2.0 million in outstanding debt held by Brainlab AG which was set to mature on December 31, 2018. Additionally, the company extended the maturi…

MRI Interventions Reports Second Quarter Results

Biologics Trials, CE Mark Clearances and FDA Submissions Expand Market Opportunities Biologics Trials, CE Mark Clearances and FDA Submissions Expand Market Opportunities
Report incorrect company information

MRI Interventions Blogs

MRI Interventions Announces FDA Clearance of ClearPoint® 2.0 Next-Generation Software Platform

Initial Limited Market Release Shipments to Commence Immediately IRVINE, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced FDA clearance for the company’s latest software platform – ClearPoint® 2.0. The platform’s new features are designed to improve…

MRI Interventions, Inc. to Announce Third Quarter 2018 Results on November 12

IRVINE, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) announced that it will release financial results for its 2018 third quarter, which ended September 30, 2018, on Monday, November 12, 2018 after the market close. The company will subsequently conduct a conferen…

MRI Interventions Congratulates Axovant on First Patient Dosing in New Gene Therapy Clinical Study for Patients with Parkinson’s Disease

Initial Data Expected in First Half of 2019 IRVINE, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- MRI Interventions (OTCQB:MRIC) congratulates Axovant Sciences Ltd. on the dosing of its first patient in a clinical study of AXO-Lenti-PD, also known as OXB-102, an investigational gene therapy for t…

MRI Interventions Congratulates Monteris Medical on FDA Clearance of NeuroBlate Laser Probe

Clearance Resolves Outstanding FDA Advisory Notice Issues IRVINE, Calif., Oct. 24, 2018 (GLOBE NEWSWIRE) -- MRI Interventions (OTCQB:MRIC) congratulates Monteris Medical on the FDA Clearance of its new NeuroBlate Optic Laser Probe. The new probe replaces a previous metallic thermocouple with a n…

MRI Interventions Signs Exclusive Distribution Agreement with Clinical Laserthermia Systems (CLS) for U.S. and Canada

Agreement Enables MRI Interventions to Distribute CLS’s Precision Ablation Product Portfolio for Use in Interventional MR-Guided Procedures Beyond Previously Announced Spine and Neuro License Agreement IRVINE, Calif., Oct. 19, 2018 (GLOBE NEWSWIRE) -- MRI Interventions (OTCQB:MRIC) and CLS AB i…

Clinical Laserthermia Systems (CLS) Signs Exclusive Distribution Agreement with MRI Interventions for USA and Canada

Framingham, MA - October 17, 2018 - CLS AB (NASDAQ FIRST NORTH: CLS B)in Lund, Sweden, with the subsidiary Clinical Laserthermia Systems Americas, Inc. (CLS Americas), and MRI Interventions (MRIC), today announced that the companies have signed an agreement granting MRI Interventions the exclusive r…
Show more

MRI Interventions Company Life and Culture

Report incorrect company information

MRI Interventions Frequently Asked Questions

  • When was MRI Interventions founded?

    MRI Interventions was founded in 1998.

  • Who are MRI Interventions key executives?

    MRI Interventions's key executives are Joseph M. Burnett, Peter G. Piferi and Harold A. Hurwitz.

  • How many employees does MRI Interventions have?

    MRI Interventions has 34 employees.

  • What is MRI Interventions revenue?

    Latest MRI Interventions annual revenue is $7.4 m.

  • What is MRI Interventions revenue per employee?

    Latest MRI Interventions revenue per employee is $217 k.

  • Who are MRI Interventions competitors?

    Competitors of MRI Interventions include Sanovas, Glaukos and C. R. Bard.

  • Where is MRI Interventions headquarters?

    MRI Interventions headquarters is located at 5 Musick, Irvine.

  • Where are MRI Interventions offices?

    MRI Interventions has an office in Irvine.

  • How many offices does MRI Interventions have?

    MRI Interventions has 1 office.